We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.33%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.05B
AUM Growth
+$527M
(+21%)
Cap. Flow
+$482M
Cap. Flow
% of AUM
15.81%
Top 10 Holdings %
Top 10 Hldgs %
28.17%
Holding
230
New
83
Increased
48
Reduced
47
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$73.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$66.4M |
| 3 |
Amazon
AMZN
|
+$65.7M |
| 4 |
Johnson & Johnson
JNJ
|
+$61.2M |
| 5 |
Mastercard
MA
|
+$61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$65M |
| 2 |
PayPal
PYPL
|
+$52M |
| 3 |
eBay
EBAY
|
+$48.4M |
| 4 |
NXP Semiconductors
NXPI
|
+$42.9M |
| 5 |
Qorvo
QRVO
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.94% |
| 2 | Technology | 31.58% |
| 3 | Communication Services | 6.58% |
| 4 | Consumer Discretionary | 4.22% |
| 5 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Tango Therapeutics
TNGX
$4.69B
| $5.18M | 0.17% |
+500,000
| New | +$5.11M |
|
127
Ericsson
ERIC
$33B
| $5.08M | 0.17% |
+466,103
| New | +$5.15M |
|
128
Nurix Therapeutics
NRIX
$2.61B
| $5.03M | 0.16% |
+144,087
| New | +$3.63M |
|
129
Immunovant
IMVT
$8.06B
| $4.97M | 0.16% |
141,170
-89,738
| -39% | -$2.7M |
|
130
NetApp
NTAP
$36.6B
| $4.96M | 0.16% |
+113,217
| New | +$4.94M |
|
|
RNAM
131
DELISTED
Avidity Biosciences
RNAM
| $4.87M | 0.16% |
172,978
+47,978
| +38% | +$1.39M |
|
132
DaVita
DVA
$12.1B
| $4.77M | 0.16% |
+55,720
| New | +$4.76M |
|
|
VISN
133
Vistance Networks Inc
VISN
$2.79B
| $4.63M | 0.15% |
514,299
+122,954
| +31% | +$1.16M |
|
|
FSDC
134
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| $4.63M | 0.15% |
+413,332
| New | +$4.42M |
|
135
Zentalis Pharmaceuticals
ZNTL
$352M
| $4.51M | 0.15% |
137,884
+94,158
| +215% | +$3.3M |
|
136
Icon
ICLR
$12.6B
| $4.51M | 0.15% |
+23,580
| New | +$4.33M |
|
|
137
Intel
INTC
$510B
| $4.44M | 0.15% |
85,814
-1,249,446
| -94% | -$65M |
|
138
Nu Skin
NUS
$253M
| $4.44M | 0.15% |
+88,581
| New | +$4.2M |
|
139
Orchestra BioMed
OBIO
$253M
| $4.4M | 0.14% |
+400,000
| New | +$4.49M |
|
140
Analog Devices
ADI
$184B
| $4.21M | 0.14% |
36,051
-62,578
| -63% | -$7.33M |
|
141
Cadence Design Systems
CDNS
$92.8B
| $4M | 0.13% |
37,474
-111,662
| -75% | -$11.7M |
|
|
PRVL
142
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $3.92M | 0.13% |
385,480
+56,345
| +17% | +$756K |
|
143
Envista
NVST
$4.66B
| $3.89M | 0.13% |
157,621
+107,506
| +215% | +$2.48M |
|
144
Arrowhead Research
ARWR
$12.2B
| $3.76M | 0.12% |
+87,365
| New | +$3.77M |
|
|
SUMO
145
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $3.6M | 0.12% |
+165,000
| New | +$3.9M |
|
|
CMPS
146
Compass Pathways
CMPS
$1.83B
| $3.59M | 0.12% |
+102,944
| New | +$3.7M |
|
147
CVS Health
CVS
$126B
| $3.59M | 0.12% |
+61,476
| New | +$3.83M |
|
148
GoodRx Holdings
GDRX
$1.11B
| $3.48M | 0.11% |
+62,500
| New | +$3.31M |
|
149
Pliant Therapeutics
PLRX
$65M
| $3.44M | 0.11% |
+152,000
| New | +$3.8M |
|
|
FRLN
150
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $3.22M | 0.11% |
+13,761
| New | +$3.45M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Woodline Partners held 230 positions worth $3.05B, up 21% from $2.52B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Woodline Partners deployed $482M of net new capital in Q3 2020, opening 83 new positions and adding to 48 existing holdings. Its largest new stake was Microchip Technology: 1,413,308 shares worth $72.6M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Intel, an estimated $65M trimmed.
- Woodline Partners's largest Q3 2020 buy was Microchip Technology: 1,413,308 shares worth $72.6M.
- Woodline Partners added most to Johnson & Johnson in Q3 2020, an estimated $61.2M increase.
- Woodline Partners's biggest Q3 2020 reduction was Intel, cutting an estimated $65M.
- Woodline Partners fully exited PayPal in Q3 2020, selling an estimated $52M.
- Woodline Partners's ten largest holdings make up 28% of its $3.05B portfolio in Q3 2020.
- Woodline Partners opened 83 new positions and closed 52 in Q3 2020.
- Woodline Partners's portfolio value rose 21% quarter-over-quarter to $3.05B.
Based on Woodline Partners's 13F filing for Q3 2020, filed 16 Nov 2020.